A crucial hub gene for PCa is TP53, which is overexpressed in PRAD, and the status of TP53 mutations has been demonstrated to stratify PCa, leading to variations in the molecular mechanism [73,74]. Here, TP53 is linked to prostate adenocarcinoma.